Literature DB >> 1931440

Basic fibroblast growth factor in human melanoma.

U Rodeck1, D Becker, M Herlyn.   

Abstract

Basic fibroblast growth factor (bFGF) is a major factor contributing to human melanoma cell growth. bFGF is produced constitutively by cells from each stage of the disease, but not by normal melanocytes, although the latter cells are dependent on the factor for growth in vitro. Two lines of evidence suggest that bFGF functions in an autocrine manner in melanoma: (1) inhibition of bFGF activity by bFGF-specific antibodies or antisense sequences suppresses melanoma cell growth in vitro; and (2) retrovirus-mediated transfer of a bFGF cDNA into normal murine melanocytes renders the recipient cell bFGF-independent. Constitutive production of bFGF is not by itself sufficient for the establishment of the transformed phenotype, however, since bFGF-expressing melanocytes are neither immortalized nor tumorigenic in nude mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931440

Source DB:  PubMed          Journal:  Cancer Cells        ISSN: 1042-2196


  15 in total

1.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.

Authors:  Dongfang Liu; Zachary Shriver; Ganesh Venkataraman; Yosuf El Shabrawi; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  Angiogenic capacity and lung-colonizing potential in vivo is increased in weakly metastatic B16F1 cells and decreased in highly metastatic BL6 cells by phorbol esters.

Authors:  C A La Porta; R Comolli
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

3.  Novel Ras antagonist blocks human melanoma growth.

Authors:  B Jansen; H Schlagbauer-Wadl; H Kahr; E Heere-Ress; B X Mayer; H Eichler; H Pehamberger; M Gana-Weisz; E Ben-David; Y Kloog; K Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 4.  Molecular aspects of melanocytic dysplastic nevi.

Authors:  Mahmoud Rezk Abd-Elwahed Hussein; Gary Stewart Wood
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

5.  RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.

Authors:  K L van Golen; Z F Wu; X T Qiao; L Bao; S D Merajver
Journal:  Neoplasia       Date:  2000 Sep-Oct       Impact factor: 5.715

6.  Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors.

Authors:  G L Nicolson; M Nakajima; J L Herrmann; D G Menter; P G Cavanaugh; J S Park; D Marchetti
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 7.  Brain metastases in melanoma: roles of neurotrophins.

Authors:  Yvonne Denkins; Jane Reiland; Madhuchhanda Roy; Neeta D Sinnappah-Kang; Jennifer Galjour; Brian P Murry; Jason Blust; Rebecca Aucoin; Dario Marchetti
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

8.  Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.

Authors:  Kenneth L van Golen; Li Wei Bao; Quintin Pan; Fred R Miller; Zhi Fen Wu; Sofia D Merajver
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 9.  Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm.

Authors:  R S Kerbel
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

Review 10.  Brain-metastatic melanoma: a neurotrophic perspective.

Authors:  Dario Marchetti; Yvonne Denkins; Jane Reiland; Andrea Greiter-Wilke; Jennifer Galjour; Brian Murry; Jason Blust; Madhuchhanda Roy
Journal:  Pathol Oncol Res       Date:  2003-10-07       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.